Jung-Chool Kim
Chief Executive Officer chez APROGEN BIOLOGICS INC.
Fortune : 1 M $ au 31/03/2024
Profil
Jung-Chool Kim is currently the Chief Executive Officer & Director at Aprogen Biologics, Inc. since 2012.
He is also a Director at Aprogen, Inc. and E&M Revolution Co., Ltd.
Additionally, he has previously worked as the Chief Executive Officer at Chunggei Pharm Co. Ltd.
and as a Director at Aprogen, Inc. and Aprogen Biologics, Inc. (Korea).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
APROGEN, INC
0,42% | 12/04/2024 | 1 123 427 ( 0,42% ) | 1 M $ | 31/03/2024 |
APROGEN BIOLOGICS
0,00% | 28/03/2024 | 21 880 ( 0,00% ) | 3 103 $ | 31/03/2024 |
Postes actifs de Jung-Chool Kim
| Sociétés | Poste | Début |
|---|---|---|
| APROGEN BIOLOGICS INC. | Chief Executive Officer | 01/04/2012 |
| APROGEN MEDICINES INC. | Director/Board Member | - |
E&M Revolution Co., Ltd.
 E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Director/Board Member | - |
Anciens postes connus de Jung-Chool Kim
| Sociétés | Poste | Fin |
|---|---|---|
Aprogen Biologics, Inc. (Korea)
 Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | - |
| Chunggei Pharm Co. Ltd. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APROGEN BIOLOGICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Aprogen, Inc. | |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| Chunggei Pharm Co. Ltd. | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Health Technology |
